RICT 2017 – 53rd International Conference on Medicinal Chemistry

  • Author/Organiser: LDO Conferences
  • Event Website: http://www.rict2017.org
  • Event Date: $eventDateStart
  • Event Type: Conference
  • Venue: University of Toulouse, Toulouse, France

View Full Event Details

The event aims to help to structure and strengthen research, innovation, and development in the field of medicinal chemistry. Theis year's congress will be devoted to "Drug Discovery & Selection".


Topics

  • Immunotherapy-Oncology
  • Emerging & Neglected Diseases
  • Breakthrough in Technologies for Drug Discovery
  • Tackling the Delivery of Biologics
  • Access to Novel Molecular Entities
  • Case Studies


Selected Speakers

  • Dr Jean-Philippe ANNEREAU (ALEXION, Paris, France)
  • Identifying High Quality, Potent and Selective Inhibitors of ATM Kinase for Oncology Therapies: Discovery of AZD0156
    Dr Bernard BARLAAM (ASTRAZENECA, Macclesfield, United Kingdom)
  • Peptide Drugs to Target GPCR- State of the Art and Innovative Application
    Prof. Annette BECK-SICKINGER (LEIPZIG UNIVERSITY, Leipzig, Germany)
  • Discovery of PF-06840003, a Novel IDO Inhibitor for Cancer Immunotherapy
    Dr Stefano CROSIGNANI (ITEOS THERAPEUTICS SA, Gosselies, Belgium)
  • Sugars and Proteins
    Prof. Ben DAVIS (OXFORD UNIVERSITY, Oxford, United Kingdom)
  • Xeno Nucleic Acids (XNA) in vivo : A New Medicinal Chemistry Approach?
    Prof. Piet HERDEWIJN (KU LEUVEN, Leuven, Belgium)
  • Monitoring the Antagonist-Protein and Protein-Protein Interactions with NMR and X-ray: Inhibitors of the p53-Mdm2 and Immune Checkpoint PD-1/PD-L1 Interactions
    Prof. Tad HOLAK (MAX PLANCK INSTITUTE OF BIOCHEMISTRY, Martinsried, Germany)
  • Engineering Alphabodies to Generate Potent Druggable Inhibitors of Intracellular Protein-Protein Interactions
    Dr Ignace LASTERS (COMPLIX, Zwijnaarde, Belgium)
  • Raising the Gold Standard: Design & Development of Highly Selective JAK3 Probes (Janus Kinase 3)
    Prof. Stefan LAUFER (UNIVERSITY TÜBINGEN, Tübingen, Germany)
  • Dr Meyer NICOLAS (ONCOPOLE TOULOUSE, Toulouse, France)
  • One-pot Cascade Syntheses Using Multicomponent Reactions and Biocatalysis
    Prof. Romano ORRU (VU UNIVERSITY AMSTERDAM, Amsterdam, The Netherlands)
  • First-in-class Extracellular Modulators of Receptor Tyrosine Kinases: from Theory to Practice
    Prof. Didier ROGNAN (UNIVERSITY OF STRASBOURG, Illkirch, France)
  • Allosteric Inhibitors of Dengue and Zika Virus NS3/NS2B Proteases
    Prof. Tanja SCHIRMEISTER (UNIVERSITY OF MAINZ, Mainz, Germany)
  • De Novo Drug Design — Inspiration from Nature
    Prof. Gisbert SCHNEIDER (ETH ZÜRICH, Zürich, Switzerland)
  • Structure-based Drug Design (SBDD) in Medicinal Chemistry-enabled Drug Discovery
    Dr Hong SHEN (F. HOFFMANN-LA ROCHE, Shanghai, China)
  • Discovery of Leniolisib, a Novel and Selective PI3K? Inhibitor for Autoimmune and Inflammatory Diseases
    Dr Nicolas SOLDERMANN (NOVARTIS, Basel, Switzerland)
  • Bioactive Ribosomal and Non-Ribosomal Peptides from Nature - Structures, Biosynthesis and Engineering Options
    Prof. Roderich D. SÜSSMUTH (TECHNICAL UNIVERSITY BERLIN, Berlin, Germany)
  • Chemoselective and Biocompatible Reactions, New Tools for Heterocyclic Chemistry and Chemical Biology
    Dr Frédéric TARAN (CEA/SACLAY, Gif-sur-Yvette, France)
  • Development of Dual IGF1R/INSR Inhibitors a Case Study
    Dr Heather TYE (EVOTEC (UK) LTD, Abingdon, United Kingdom)
  • Novel Small Molecule MerTK Inhibitors and their Biological Uses
    Prof. Xiaodong WANG (UNIVERSITY OF NORTH CAROLINA, Chapel Hill, United States)

 

Article Views: 393

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter


A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH